Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details

Comments(1)

Leptin-signaling inhibition results in efficient anti-tumor activity in estrogen receptor positive or negative breast cancer

Ruben Rene Gonzalez email, Amber Watters email, Yanbo Xu email, Udai P Singh email, David R Mann email, Bo R Rueda email and Manuel L Penichet email

Breast Cancer Research 2009, 11:R36doi:10.1186/bcr2321

Leptin-signaling inhibition trial

Kathleen Riley   (12 November 2009)  Self-employed free-lance writer email

Are there currently any clinical trials involving leptin-signaling inhibition for Stage IV breast cancer patients?

Competing interests

None declared

top

Have something to say? Post a comment on this article!

Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.